Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Case Comprehensive Cancer Center
- Study ID
- NCT07040501
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Chat GPT — DEVICEOn the date of appointment, participants will be given up to 30 minutes, to interact with a pre-prompted Chat GPT (Prostate Pathology Guide) using a Cleveland clinic device.
Study Details
The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Key Dates
- First listed
- Jun 27, 2025
- Start date
- Jun 30, 2026
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Chat GPT - Prostate Pathology Guide
Primary Outcome Measure
Accuracy as assessed by the rate of correctly identified and risk-stratified participants diagnosed with prostate cancer [ Time Frame: Post intervention(approximately 70 minutes) ]
Central Contacts
- Zeyad Schwen, MD216-444-2200
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute | Cleveland | Ohio | 44195 | Zeyad Schwen, MD |
Find similar trials in Cleveland, OH
Nationwide
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Tuscaloosa, Alabama
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPHASE1 · Recruiting · Amgen · Duarte, California
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · La Jolla, California